Two Roads Shared Trust - LeaderShares Activist Leaders ETF
US ˙ ARCA

Introduction

This page provides a comprehensive analysis of the known insider trading history of Seth Rudnick. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Seth Rudnick has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:GTHX / G1 Therapeutics, Inc. Director 0
Director 20,000
US:ARLZ / Aralez Pharmaceuticals Inc. Director 15,000
US:SQBK / Square 1 Financial Inc Director 0
US:POZN / Pozen, Inc. Director 0
US:ACTV / Two Roads Shared Trust - LeaderShares Activist Leaders ETF 10% Owner 5,088,299
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Seth Rudnick. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ACTV / Two Roads Shared Trust - LeaderShares Activist Leaders ETF - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ACTV / Two Roads Shared Trust - LeaderShares Activist Leaders ETF. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ACTV / Two Roads Shared Trust - LeaderShares Activist Leaders ETF Insider Trades
Insider Sales ACTV / Two Roads Shared Trust - LeaderShares Activist Leaders ETF - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ACTV / Two Roads Shared Trust - LeaderShares Activist Leaders ETF. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2012-03-05 ACTV GREEN L STEPHEN 48,000 16.0008 48,000 16.0008 768,038 730
2012-03-02 ACTV GREEN L STEPHEN 146,486 16.0000 146,486 16.0000 2,343,776
2012-03-01 ACTV GREEN L STEPHEN 92,200 16.0004 92,200 16.0004 1,475,237
2012-02-29 ACTV GREEN L STEPHEN 45,986 16.0046 45,986 16.0046 735,988
2012-02-28 ACTV GREEN L STEPHEN 62,300 16.0017 62,300 16.0017 996,906
2012-02-27 ACTV GREEN L STEPHEN 78,400 15.8511 78,400 15.8511 1,242,726
2011-05-31 ACTV GREEN L STEPHEN 1,371,701 15.0000 1,371,701 15.0000 20,575,515

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ACTV / Two Roads Shared Trust - LeaderShares Activist Leaders ETF Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Seth Rudnick as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2021-06-30 2021-06-29 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -7,969 0 -100.00
2021-06-30 2021-06-29 4 GTHX G1 Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -2,031 11,859 -14.62
2021-06-30 2021-06-29 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -10,000 4,389 -69.50 22.35 -223,477 98,084
2021-06-30 2021-06-29 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 2,031 14,389 16.43 0.30 609 4,317
2021-06-30 2021-06-29 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 7,969 12,358 181.57 0.39 3,108 4,820
2021-06-21 2021-06-17 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
A - Award 19,620 19,620
2021-06-21 2021-06-17 4 GTHX G1 Therapeutics, Inc.
Common Stock
A - Award 4,389 4,389
2020-12-29 2020-12-24 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -924 5,266 -14.93 20.10 -18,572 105,846
2020-12-23 2020-12-23 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -13,118 6,190 -67.94 20.18 -264,757 124,931
2020-12-23 2020-12-22 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -18,974 19,308 -49.56 20.33 -385,702 392,491
2020-12-10 2020-12-10 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -546 38,282 -1.41 20.00 -10,921 765,709
2020-12-10 2020-12-09 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -5,773 38,828 -12.94 20.32 -117,284 788,826
2020-12-10 2020-12-08 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -13,161 44,601 -22.78 20.19 -265,694 900,405
2020-12-03 2020-12-01 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -520 57,762 -0.89 20.09 -10,449 1,160,710
2020-06-23 2020-06-22 4 LQDA Liquidia Technologies Inc
Non-Qualified Stock Option (right to buy)
A - Award 20,000 20,000
2020-06-12 2020-06-11 4 GTHX G1 Therapeutics, Inc.
Stock Option (right to buy)
A - Award 20,000 20,000
2019-09-03 2019-08-29 4 LQDA Liquidia Technologies Inc
Nonqualified Stock Option (right to buy)
A - Award 7,500 7,500
2019-06-14 2019-06-12 4 GTHX G1 Therapeutics, Inc.
Stock Option (right to buy)
A - Award 20,000 20,000
2018-12-04 2018-12-04 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -9,393 7,969 -54.10
2018-12-04 2018-12-04 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -607 0 -100.00
2018-12-04 2018-12-04 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -116 0 -100.00 40.00 -4,640
2018-12-04 2018-12-04 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -9,884 116 -98.84 39.31 -388,506 4,560
2018-12-04 2018-12-04 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 9,393 10,000 1,547.45 0.39 3,663 3,900
2018-12-04 2018-12-04 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 607 607 0.39 237 237
2018-11-07 2018-11-05 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -10,000 607 -94.28
2018-11-07 2018-11-05 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -10,000 0 -100.00 41.53 -415,347
2018-11-07 2018-11-05 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 10,000 10,000 0.39 3,900 3,900
2018-10-05 2018-10-04 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -10,000 10,607 -48.53
2018-10-05 2018-10-04 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -1,980 0 -100.00 49.99 -98,981
2018-10-05 2018-10-04 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -8,020 1,980 -80.20 49.65 -398,229 98,316
2018-10-05 2018-10-04 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 10,000 10,000 0.39 3,900 3,900
2018-09-06 2018-09-04 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -10,000 20,607 -32.67
2018-09-06 2018-09-04 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -500 0 -100.00 60.31 -30,155
2018-09-06 2018-09-04 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -9,500 500 -95.00 59.93 -569,328 29,965
2018-09-06 2018-09-04 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 10,000 10,000 0.39 3,900 3,900
2018-08-06 2018-08-06 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -10,000 30,607 -24.63
2018-08-06 2018-08-06 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -10,000 0 -100.00 50.69 -506,901
2018-08-06 2018-08-06 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 10,000 10,000 0.39 3,900 3,900
2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock
48,284
2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock
48,284
2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock
48,284
2018-06-11 2018-06-07 4 GTHX G1 Therapeutics, Inc.
Stock Option (right to buy)
A - Award 10,000 10,000
2017-07-13 2017-07-11 4 GTHX G1 Therapeutics, Inc.
Stock Option (right to buy)
A - Award 20,000 20,000
2017-05-24 2017-05-22 4 GTHX G1 Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -8,271 0 -100.00
2017-05-24 2017-05-22 4 GTHX G1 Therapeutics, Inc.
Common Stock
C - Conversion 2,757 58,282 4.97
2017-05-16 3 GTHX G1 Therapeutics, Inc.
Common Stock
111,050
2017-05-16 3 GTHX G1 Therapeutics, Inc.
Common Stock
111,050
2017-05-12 2017-05-11 4 ARLZ Aralez Pharmaceuticals Inc.
Director Stock Option (right to buy)
A - Award 15,000 15,000
2017-05-12 2017-05-11 4 ARLZ Aralez Pharmaceuticals Inc.
Common Shares, without par value
A - Award 7,500 86,891 9.45
2017-03-17 2017-03-15 4 ARLZ Aralez Pharmaceuticals Inc.
Common Shares, without par value
P - Purchase 15,000 79,391 23.30 2.26 33,950 179,686
2016-12-12 2016-11-23 4 ARLZ Aralez Pharmaceuticals Inc.
Common Shares, without par value
G - Gift 30,000 30,000
2016-12-12 2016-11-23 4 ARLZ Aralez Pharmaceuticals Inc.
Common Shares, without par value
G - Gift -30,000 64,391 -31.78
2016-11-15 2016-11-11 4 ARLZ Aralez Pharmaceuticals Inc.
Common Shares, without par value
P - Purchase 30,000 94,391 46.59 4.77 143,121 450,311
2016-06-20 2016-06-16 4 ARLZ Aralez Pharmaceuticals Inc.
Employee Stock Option (right to buy)
A - Award 15,000 15,000
2016-06-20 2016-06-16 4 ARLZ Aralez Pharmaceuticals Inc.
Common Shares, without par value
A - Award 7,500 64,391 13.18
2016-02-09 2016-02-05 4 ARLZ Aralez Pharmaceuticals Inc.
Common Shares
J - Other 47,501 47,501
2015-10-08 2015-10-06 4 SQBK SQUARE 1 FINANCIAL INC
Restricted Stock Units
D - Sale to Issuer -1,031 0 -100.00
2015-10-08 2015-10-06 4 SQBK SQUARE 1 FINANCIAL INC
Class A Common Stock
D - Sale to Issuer -31,145 0 -100.00
2015-06-25 2015-06-23 4 POZN POZEN INC /NC
Stock Option (right to buy)
M - Exercise -6,107 0 -100.00
2015-06-25 2015-06-23 4 POZN POZEN INC /NC
Stock Option (right to buy)
M - Exercise -6,107 0 -100.00
2015-06-25 2015-06-23 4 POZN POZEN INC /NC
Stock Option (right to buy)
M - Exercise -24,430 0 -100.00
2015-06-25 2015-06-23 4 POZN POZEN INC /NC
Stock Option (right to buy)
M - Exercise -3,053 0 -100.00
2015-06-25 2015-06-23 4 POZN POZEN INC /NC
Common Stock
F - Taxes -13,987 47,501 -22.75 12.02 -168,124 570,962
2015-06-25 2015-06-23 4 POZN POZEN INC /NC
Common Stock
M - Exercise 6,107 61,488 11.03 4.44 27,115 273,007
2015-06-25 2015-06-23 4 POZN POZEN INC /NC
Common Stock
M - Exercise 6,107 55,381 12.39 5.40 32,978 299,057
2015-06-25 2015-06-23 4 POZN POZEN INC /NC
Common Stock
M - Exercise 27,483 49,274 126.12 3.93 108,008 193,647
2015-06-12 2015-06-10 4 POZN POZEN INC /NC
Common Stock
A - Award 9,390 31,181 43.09
2015-02-05 2015-02-03 4 SQBK SQUARE 1 FINANCIAL INC
Class A Common Stock
A - Award 1,031 32,176 3.31
2014-06-18 2014-06-16 4 SQBK Square 1 Financial Inc
Trust Preferred Securities
C - Conversion -300 0 -100.00
2014-06-18 2014-06-16 4 SQBK Square 1 Financial Inc
Class A Common Stock
C - Conversion 30,000 30,000
2014-06-09 2014-06-04 4 POZN POZEN INC /NC
Common Stock
A - Award 9,291 21,791 74.33
2014-04-16 3 SQBK Square 1 Financial Inc
Class A Common Stock
2,290
2014-04-16 3 SQBK Square 1 Financial Inc
Class A Common Stock
2,290
2013-06-11 2013-06-06 4 POZN POZEN INC /NC
Stock Option (right to buy)
A - Award 5,000 5,000
2013-06-11 2013-06-06 4 POZN POZEN INC /NC
Common Stock
A - Award 5,000 12,500 66.67
2012-06-15 2012-06-07 4 POZN POZEN INC /NC
Stock Option (right to buy)
A - Award 5,000 5,000
2012-06-15 2012-06-07 4 POZN POZEN INC /NC
Common Stock
A - Award 5 7,500 0.07
2012-03-06 2012-03-05 4 ACTV ACTIVE NETWORK INC
Common Stock
S - Sale -48,000 5,088,299 -0.93 16.00 -768,038 81,416,855
2012-03-06 2012-03-02 4 ACTV ACTIVE NETWORK INC
Common Stock
S - Sale -146,486 5,136,299 -2.77 16.00 -2,343,776 82,180,784
2012-03-02 2012-03-01 4 ACTV ACTIVE NETWORK INC
Common Stock
S - Sale -92,200 5,282,785 -1.72 16.00 -1,475,237 84,526,673
2012-03-02 2012-02-29 4 ACTV ACTIVE NETWORK INC
Common Stock
S - Sale -45,986 5,374,985 -0.85 16.00 -735,988 86,024,485
2012-02-29 2012-02-28 4 ACTV ACTIVE NETWORK INC
Common Stock
S - Sale -62,300 5,420,971 -1.14 16.00 -996,906 86,744,752
2012-02-29 2012-02-27 4 ACTV ACTIVE NETWORK INC
Common Stock
S - Sale -78,400 5,483,271 -1.41 15.85 -1,242,726 86,915,877
2011-06-02 2011-05-31 4 ACTV ACTIVE NETWORK INC
Common Stock
C - Conversion 23,546 23,546
2011-06-02 2011-05-31 4 ACTV ACTIVE NETWORK INC
Common Stock
S - Sale -1,371,701 5,561,671 -19.78 15.00 -20,575,515 83,425,065
2011-06-02 2011-05-31 4 ACTV ACTIVE NETWORK INC
Common Stock
C - Conversion 6,933,372 6,933,372
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)